These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14102460)

  • 1. [ORAL TREATMENT OF HYPERAMMONIEMIA BY CALCIUM ALPHA-KETOGLUTARATE].
    DEUIL R; GODARD F; GENTILHOMME C
    Presse Med (1893); 1964 Jan; 72():25-6. PubMed ID: 14102460
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyperammonemia and hepatic insufficiency].
    SOBERON G; FLORES G; ROSADO A; TORRES GALLARDO J; MORA J; MAGGIO R
    Gac Med Mex; 1963 Mar; 93():203-23. PubMed ID: 13989778
    [No Abstract]   [Full Text] [Related]  

  • 3. [TRIALS OF PROTECTION AGAINST EXPERIMENTAL HYPERAMMONIEMIA].
    BLANPIN O; VALLEE D
    Therapie; 1963; 18():1379-92. PubMed ID: 14117534
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma alpha-ketoglutarate in urea cycle enzymopathies and its role as a harbinger of hyperammonemic coma.
    Batshaw ML; Walser M; Brusilow SW
    Pediatr Res; 1980 Dec; 14(12):1316-9. PubMed ID: 7208146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MECHANISM OF HEPATIC COMA.
    LABBY DH; HUTCHINSON JH; STAHL J; BOCKEL R; IMLER M
    Biochem Clin; 1964; 3():245-62. PubMed ID: 14270165
    [No Abstract]   [Full Text] [Related]  

  • 6. [Arginase and experimental hyperammoniemia. II. Action of arginase on experimental portacaval encephalopathy in the dog].
    AIMARD G; MAILLET P; VILLAROS J; DUFFRENE D
    Presse Med (1893); 1962 May; 70():1204-6. PubMed ID: 13859792
    [No Abstract]   [Full Text] [Related]  

  • 7. [Present-day therapy of hepatic encephalopathy (author's transl)].
    Imler M
    MMW Munch Med Wochenschr; 1976 Dec; 118(52-53):1685-94. PubMed ID: 827698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance of hyperammoniemia].
    FASEL J; MAGNENAT P
    Praxis; 1963 Feb; 52():240-2. PubMed ID: 13944488
    [No Abstract]   [Full Text] [Related]  

  • 9. [HYPERAMMONIEMIA OF RESPIRATORY INSUFFICIENCY].
    PERRET C; MONTANI S; MAGNENAT P
    Helv Med Acta; 1964 Nov; 31():506-11. PubMed ID: 14335457
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of ornighine alpha-ketoglutarate on hyperammoniemia in the cirrhotic patient].
    Michel H; Ogé P; Bertrand L
    Presse Med (1893); 1971 Apr; 79(19):867-8. PubMed ID: 5576498
    [No Abstract]   [Full Text] [Related]  

  • 11. Ornicetil on encephalopathy. Effect of ornicetil (ornithine alpha-ketoglutarate) on encephalopathy in patients with acute and chronic liver disease.
    Chainuvati T; Plengvanit U; Viranuvatti V
    Acta Hepatogastroenterol (Stuttg); 1977 Dec; 24(6):434-9. PubMed ID: 602619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ON 3 CASES OF PORTACAVAL ANASTOMOSIS WELL ENDURED DESPITE A PROLONGED HYPERAMMONIEMIA].
    AUBERTIN E; AUBERTIN J; WONE C
    Toulouse Med; 1964 Jan; 65():27-52. PubMed ID: 14136104
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha-ketoglutaramate, a neurotoxic agent in hepatic coma.
    Vergara F; Duffy TE; Plum F
    Trans Assoc Am Physicians; 1973; 86():255-63. PubMed ID: 4788800
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of experimental and clinical hyperammonaemia with ornithine-alpha-ketoglutarate].
    Szám I; Szentner J; Hegedüs-Wein I; Vass A; Szilárd T
    Wien Med Wochenschr; 1974 May; 124(20):319-25. PubMed ID: 4829691
    [No Abstract]   [Full Text] [Related]  

  • 15. [On therapy of hepatic coma with metabolites of the urea cycle, glutamate and alpha-ketoglutarate].
    Meuret G; Beck K; Keul J; Gruenagel HH
    Dtsch Med Wochenschr; 1968 Jun; 93(24):1194-7. PubMed ID: 5651556
    [No Abstract]   [Full Text] [Related]  

  • 16. [Alpha-ketoglutarate and glutamate content of the rat brain in experimental hepatic coma].
    Hilgier W
    Neuropatol Pol; 1980; 18(1):121-6. PubMed ID: 7383346
    [No Abstract]   [Full Text] [Related]  

  • 17. Branched-chain amino acids and ammonia metabolism in liver disease: therapeutic implications.
    Holecek M
    Nutrition; 2013 Oct; 29(10):1186-91. PubMed ID: 23756281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an experimental rat model of hyperammonemic encephalopathy and evaluation of the effects of rifaximin.
    Tamaoki S; Suzuki H; Okada M; Fukui N; Isobe M; Saito T
    Eur J Pharmacol; 2016 May; 779():168-76. PubMed ID: 26980242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DETERMINATION OF AMMONIA IN DEPROTEINIZED BLOOD].
    KISFALUDY S; BRULICH M
    Kiserl Orvostud; 1964 Apr; 16():208-13. PubMed ID: 14155572
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of alterations in blood pH on distribution of ammonia from blood to cerebrospinal fluid in patients in hepatic coma.
    WARREN KS; IBER FL; DOELLE W; SHERLOCK S
    J Lab Clin Med; 1960 Nov; 56():687-94. PubMed ID: 13783219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.